- Home
- DPRO vs INMB Comparison
DPRO vs INMB Comparison
Compare DPRO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- INMB
- Stock Information
- Founded
- DPRO 1998
- INMB 2015
- Country
- DPRO Canada
- INMB United States
- Employees
- DPRO N/A
- INMB N/A
- Industry
- DPRO Aerospace
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- INMB Health Care
- Exchange
- DPRO Nasdaq
- INMB Nasdaq
- Market Cap
- DPRO 81.2M
- INMB 68.9M
- IPO Year
- DPRO N/A
- INMB 2019
- Fundamental
- Price
- DPRO $4.90
- INMB $2.05
- Analyst Decision
- DPRO Strong Buy
- INMB Buy
- Analyst Count
- DPRO 2
- INMB 4
- Target Price
- DPRO $6.50
- INMB $9.53
- AVG Volume (30 Days)
- DPRO 1.7M
- INMB 2.0M
- Earning Date
- DPRO 08-11-2025
- INMB 08-07-2025
- Dividend Yield
- DPRO N/A
- INMB N/A
- EPS Growth
- DPRO N/A
- INMB N/A
- EPS
- DPRO N/A
- INMB N/A
- Revenue
- DPRO $5,250,872.00
- INMB $50,000.00
- Revenue This Year
- DPRO $69.58
- INMB $142.83
- Revenue Next Year
- DPRO $100.68
- INMB $14,780.90
- P/E Ratio
- DPRO N/A
- INMB N/A
- Revenue Growth
- DPRO 17.08
- INMB N/A
- 52 Week Low
- DPRO $1.55
- INMB $1.89
- 52 Week High
- DPRO $7.31
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- DPRO 58.27
- INMB 34.57
- Support Level
- DPRO $3.85
- INMB $1.94
- Resistance Level
- DPRO $4.55
- INMB $2.44
- Average True Range (ATR)
- DPRO 0.33
- INMB 0.13
- MACD
- DPRO 0.04
- INMB 0.01
- Stochastic Oscillator
- DPRO 91.55
- INMB 19.43
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.